Capital Flow Monitor · Sponsors · CIK 1809726
Claris Biotherapeutics, Inc.
475 MAGELLAN AVE, HALF MOON BAY, CA, 94019 · 201-344-7638
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$121.5M
Sold
$55.7M
% sold
45.9%
Investors
14
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-08-12 | D/A ·current | 506(b) | $121.5M | $55.7M | 45.9% | 14 | EDGAR ↗ |
| 2026-08-07 | D | 506(b) | $121.5M | $55.7M | 45.9% | 14 | EDGAR ↗ |
| 2025-09-22 | D | 506(b) | $2.3M | $2.3M | 100.0% | 6 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Stephen Brady — Executive Officer / Director, Half Moon Bay, CA
1 other raise
- Tempest Therapeutics, Inc. $4.1M of $4.1M · 100.0%
-
Reza Dana — Director, Half Moon Bay, CA
2 other raises
- GelMEDIX, Inc. $747K of $2.5M · 29.9%
- SightStream Biotherapeutics, Inc. $1.8M of $1.8M · 100.0%
- Kenneth Harrison — Director, Half Moon Bay, CA
- Marc de Garidel — Director, Half Moon Bay, CA
- Meredith Fisher — Director, Half Moon Bay, CA
- Henry Rath — Executive Officer, Half Moon Bay, CA
- Susan Orr — Executive Officer, Half Moon Bay, CA
-
Michael Dybbs — Director, Half Moon Bay, CA
3 other raises
- Abcuro, Inc. $39.4M of $176.5M · 22.3%
- Delfi Diagnostics, Inc. $34.3M of $60.0M · 57.2%
- Samsara Opportunity Fund, L.P. $98.0M of $200.0M · 49.0%
- Matt Hobson — Director, Half Moon Bay, CA
- Maha Radhakrishnan — Director, Half Moon Bay, CA
- Clarke Atwell — Executive Officer, Half Moon Bay, CA
-
Brian Baum — Executive Officer, Half Moon Bay, CA
1 other raise
- Killphonic Rights, Inc. $1.0M of $1.0M · 100.0%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.